Candida auris – an emerging fungal pathogen akin to a superbug – is categorized a public health threat due to its rapid spread, ability to colonise the skin and hospital surfaces and to cause invasive disease with a high (60%) mortality rate and multi-drug resistance. New drugs are urgently needed, and in this project, we will investigate the potential of metal (e.g. silver, copper) nanoparticles as novel anti-C.auris agents. C. auris biofilms will be produced, nanoparticle-biofilm interactions will be characterized, the ability of nanoparticles to disrupt biofilms and kill the fungus will be measured and optimal nanoparticle properties will be established.
1 Nett, J. 2019. Candida auris: An emerging pathogen “incognito”? PLOS PATHOGENS 15, 4 : e1007638.
2 Forsberg K et al. 2019. Candida auris: The recent emergence of a multidrug-resistant fungal pathogen, MEDICAL MYCOLOGY, 57, 1, 1-12
3 Kean, R et al. 2018. The comparative efficacy of antiseptics against Candida auris biofilms, INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS 52, 5, 673-677.
4 Ramage, G, 2018. Candida auris and non-albicans biofilms, MEDICAL MYCOLOGY 56, 2, S16-S16, S7.1a
5 Sherry L et al, 2017. Biofilm-Forming Capability of Highly Virulent, Multidrug-Resistant Candida auris EMERGING INFECTIOUS DISEASES 23, 2, 328-331